A qualitative study of biosimilar manufacturer and regulator perceptions on intellectual property and abbreviated approval pathways.
Louise C DruedahlAnna Birna AlmarsdóttirSofia Kälvemark SporrongMarie Louise De BruinHans HooglandTimo MinssenMarco van de WeertAaron S KesselheimAmeet SarpatwariPublished in: Nature biotechnology (2020)